Announcements Trials
Browse Landscape

Phase

Phase NA 15Phase 2 5Phase 1 5Phase 3 3Phase 1/2 3Phase 4 2Phase 2/3 1

Status

Unknown 1Recruiting 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

NIH 7OTHER 5NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 3Head & Neck 1Breast 1

Conditions

Prostatic Neoplasms 3Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Breast Neoplasms 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Congresses as Topic × Clear all
NCT06323460 2026-03-24

Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
45 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms

NCT03371719 2026-01-14

Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial

NRG Oncology

Phase 2 Active not recruiting
324 enrolled
Genitourinary

Prostatic Neoplasms

NCT06129851 2023-11-13

Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer

University of Kansas Medical Center

Phase 2 Not yet recruiting
90 enrolled
Genitourinary

Prostatic Neoplasms

NCT02387099 2022-02-23

Desiree

GBG Forschungs GmbH

Phase 2 Completed
156 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Recurrence

NCT02484339 2016-04-27

α-RT

University Hospital Freiburg

Phase 2 Unknown
274 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡